| Insuman Rapid | |
| R/Neutral by Aventis | |
| short-acting | r-DNA/GE/GM |
| U100 | None |
| Line | Insuman |
| Also known as | Neutral, "R", "Toronto" |
| Similar to | |
| Action in cats |
|
| Action in dogs |
|
| Use and Handling | |
|---|---|
| Type | soluble |
| Shelf Life | 24 months |
| When opened | 4 weeks, below 25C |
| In pen | 4 weeks, below 25C |
| Notes |
|
Insuman Rapid is Aventis' brand name for its r-DNA/GE/GM short-acting insulin[2] in its Insuman line of products[3].
Like all R or neutral insulins, nothing is added (suspensions) to alter the insulin's action or speed[4]
Other brands of the same type of insulin are: Humulin R[5] and Humulin S[6][7][8] by Eli Lilly--Actrapid[9][10] and Novolin R by Novo Nordisk.
Further Reading[]
PDF of Insuman and Lantus info sheet
References[]
- ↑ Insulins-North American Veterinary Conference-2005
- ↑ Electronic Medicines Compendium (EMC) UK-Patient Information Leaflet-Insuman Rapid
- ↑ Aventis Poster-Insuman & Lantus Insulins
- ↑ FDA-Humulin R
- ↑ R Regular Human Insulin Remedyfind.com
- ↑ Electronic Medicines Compendium (EMC) UK-Patient information Leaflet-Humulin S
- ↑ Humulin S Prescribing Information
- ↑ Lilly EU/UK Product Sheer & Time Activity Profiles
- ↑ EMEA Scientific Discussion-Actrapid
- ↑ Prescribing Novo Insulins